Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte hyperaggregation and thrombogenic dysfibrinogenemia

F Nguyen1, L Drouet, M Boisseau

  • 1Laboratoire Hématologie, Hôpital Rangueil, Toulouse, France.

Clinical Hemorheology and Microcirculation
|September 19, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sinonasal mucosal melanoma: REFCOR guidelines for diagnosis, treatment and follow-up.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

Other science opportunities at the FCC-ee.

European physical journal plus·2026
Same author

O blood usage trends in the pediatric population 2015-2019: A multi-institutional analysis.

Transfusion·2025
Same author

French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.

La Revue de medecine interne·2023
Same author

Stable Operation of a Free-Electron Laser Driven by a Plasma Accelerator.

Physical review letters·2022
Same author

Incidence of persistent postoperative opioid use in patients undergoing ambulatory surgery: a retrospective cohort study.

Anaesthesia·2022
Same journal

Suppression of macrophage enriched miRNA 210-3p improves cardiac fibrosis and cardiac function following myocardial infarction.

Clinical hemorheology and microcirculation·2026
Same journal

Downregulation of PCAF inhibits vascular smooth muscle cells senescence by reducing oxidative stress injury via activating the Nrf2/ARE pathway.

Clinical hemorheology and microcirculation·2026
Same journal

Blood viscosity values for predicting pathological stroke types (ischemic stroke, hemorrhagic stroke, and stroke mimic) at DR. Cipto Mangunkusumo National Referral Hospital.

Clinical hemorheology and microcirculation·2026
Same journal

Adaptations of blood fluidity markers to progressive resistance training in men.

Clinical hemorheology and microcirculation·2026
Same journal

Changes in whole blood viscosity in patients undergoing percutaneous or surgical intervention for aortic stenosis.

Clinical hemorheology and microcirculation·2026
Same journal

Impairment of cutaneous microcirculation and vasoreactivity in primary hypothyroidism.

Clinical hemorheology and microcirculation·2026
See all related articles

Congenital dysfibrinogenemia can cause erythrocyte hyperaggregation, a condition linked to thrombotic disorders. This study found normal erythrocyte aggregation in asymptomatic patients, suggesting a specific link between hyperaggregation and thrombosis.

Area of Science:

  • Hematology
  • Thrombosis research
  • Genetic blood disorders

Background:

  • Congenital dysfibrinogenemia is a group of inherited disorders affecting fibrinogen function.
  • The relationship between dysfibrinogenemia and thrombotic events is not fully understood.
  • Erythrocyte aggregation is a factor in blood flow and clot formation.

Purpose of the Study:

  • To investigate erythrocyte aggregation patterns in patients with congenital dysfibrinogenemia.
  • To determine if altered erythrocyte aggregation correlates with thrombotic complications.
  • To explore potential mechanisms linking dysfibrinogenemia, hyperaggregation, and thrombosis.

Main Methods:

  • Measured erythrocyte aggregation in 12 patients diagnosed with congenital dysfibrinogenemia.

Related Experiment Videos

  • Correlated aggregation results with clinical presentation, specifically the presence or absence of thrombotic disorders.
  • Assessed for other hemostatic anomalies, including coagulation inhibitor deficiencies and anti-phospholipid antibodies, in symptomatic patients.

    • Main Results:

    • Four out of 12 patients exhibited erythrocyte hyperaggregation.
    • These four patients with hyperaggregation had a history of thrombotic disorders.
    • Patients with asymptomatic dysfibrinogenemia showed normal erythrocyte aggregation.
    • No other hemostatic anomalies were identified in the symptomatic patients.

    Conclusions:

    • Erythrocyte hyperaggregation may be a significant factor in the thrombotic complications associated with congenital dysfibrinogenemia.
    • The findings suggest that erythrocyte aggregation, independent of other hemostatic defects, could contribute to thrombotic risk.
    • Further research is warranted to elucidate the precise mechanisms involved and potential therapeutic targets.